Details
5 Trials
0 Therapies
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer
Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Non-Small Cell Lung Receiving Intravenous (IV) ABBV-400